Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
ATEMPT 2.0: Adjuvant T-DM1 vs TH
for
Breast Cancer, HER2-positive Breast Cancer
Location: Houston TX, Nashville TN, Chicago IL, Plantation FL,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04893109
Phase 2, Recruiting
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Primary Myelofibrosis, Post-PV MF,
Location: Houston TX, Birmingham AL, Cincinnati OH, Canton OH
Sponsor: Telios Pharma, Inc.
Sex: All
Age: 18+
Code: NCT05280509
Phase 1, Phase 2, Recruiting
Ketorolac in Palatoplasty
for
Cleft Lip and Palate
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0+
Code: NCT04771156
Recruiting
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
for
Malignant Neoplasm of Bone and Articular Cartilage,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12 - 50
Code: NCT03093909
Phase 1, Recruiting
Rethinking Rigidity: Development of a 3D-Printed Scoliosis Brace With Varying Flexibility
for
Scoliosis Idiopathic Adolescent Treatment
Location: The Woodlands TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 8 - 18
Code: NCT06785207
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Houston TX, Dallas TX, Memphis TN, St Louis MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase 2, Phase 3, Recruiting
Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty
for
Pain, Postoperative
Location: Bellaire TX, San Antonio TX, Phoenix AZ,
Sponsor: Teikoku Pharma USA, Inc.
Sex: All
Age: 18+
Code: NCT04242407
Phase 2, Recruiting
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
Location: Houston TX, Chicago IL, Boston MA, San Francisco CA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT04883671
Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Houston TX, Aurora CO, Indianapolis IN, Cincinnati OH,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase 1, Phase 2, Recruiting
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
for
Monoclonal Gammopathy of Undetermined Significance,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05136807
Recruiting
Evaluating the Impact of a School-based Fruit and Vegetable Co-op on Cardiometabolic Child and Parents Health in a Persistent Poverty Area
for
Child Obesity, Cardiometabolic Health
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 6 - 9
Code: NCT06570707
Recruiting
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
for
HIV Infections
Location: Houston TX, Atlanta GA, Tampa FL, Miami FL,
Sponsor: ViiV Healthcare
Sex: All
Age: 6 - 12
Code: NCT05674656
Phase 1, Phase 2, Recruiting
Study of Lunresertib Alone or in Combination With RP-3500 or Zedoresertib (Debio 0123) in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Houston TX, St Louis MO, Jacksonville FL, Rochester MN,
Sponsor: Debiopharm International SA
Sex: All
Age: 12+
Code: NCT04855656
Phase 1, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Houston TX, Austin TX, Dallas TX, Oklahoma City OK,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase 1, Recruiting
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
for
Recurrent Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03629171
Phase 2, Recruiting
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
for
Obstructive Sleep Apnea, Down Syndrome
Location: Houston TX, Dallas TX, Aurora CO, Ann Arbor MI,
Sponsor: Oregon Health and Science University
Sex: All
Age: 2 - 17
Code: NCT05508971
Recruiting
Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
for
Hematologic Malignancies
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0 - 60
Code: NCT06807606
Phase 2, Recruiting
A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors
for
Select Advanced Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06598371
Phase 1, Phase 2, Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: Houston TX, San Antonio TX, Fairway KS, Dyer IN,
Sponsor: Frontier Medicines Corporation
Sex: All
Age: 18+
Code: NCT06244771
Phase 1, Phase 2, Recruiting
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions